X-ray Dose Reduction Study for Endovascular Interventional Radiology
NCT ID: NCT01599741
Last Updated: 2022-03-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2012-06-30
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique
NCT00540761
Evaluating New Radiation Techniques for Cardiovascular Imaging
NCT01621594
Measurement of Heart-carotid Pulse Wave Velocity (hcPWV) by Laser Doppler Vibrometry (LDV)
NCT05711693
Use of Large Field of View During Image Acquisition for Coronary Angiography
NCT01334931
RADIQAL Study (Radiation Dose and Image Quality Trial)
NCT06944509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ClarityIQ
Low-dose DSA (83% reducation compared to normal dose) with novel X-ray imaging technology.
Low-dose DSA (83% reduction compared to normal dose) with novel X-ray imaging technology.
Digital Subtraction Angiography (DSA) of iliac artery with reduced dose settings (83% dose reduction expected) in combination with novel X-ray imaging technology.
AlluraXper
Normal dose DSA with conventional X-ray imaging technology.
Normal dose DSA with conventional X-ray imaging technology
Digital Subtraction Angiography (DSA) of iliac artery with normal dose settings in combination with conventional X-ray imaging technology.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low-dose DSA (83% reduction compared to normal dose) with novel X-ray imaging technology.
Digital Subtraction Angiography (DSA) of iliac artery with reduced dose settings (83% dose reduction expected) in combination with novel X-ray imaging technology.
Normal dose DSA with conventional X-ray imaging technology
Digital Subtraction Angiography (DSA) of iliac artery with normal dose settings in combination with conventional X-ray imaging technology.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients already involved in a clinical trial
* Patients under the age of 18
* Pregnant or breastfeeding women
* Patients with kidney disease (eGFR \< 60)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philips Clinical & Medical Affairs Global
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marco van Strijen, MD
Role: PRINCIPAL_INVESTIGATOR
St. Antonius Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Antonius Ziekenhuis
Nieuwegein, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XCY607-100093
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.